Wed, Apr 16, 2014, 6:00 AM EDT - U.S. Markets open in 3 hrs 30 mins

Recent

% | $
Quotes you view appear here for quick access.

Dendreon Corp. Message Board

  • dwcity98 dwcity98 Dec 5, 2012 7:10 PM Flag

    Provenge GSHU Clinical Study

    This looks very promising for Provenge and PC Patients. From the article "Preclinical animal studies in Khleif’s lab found that the combination of Provenge with these two other drugs led to a significant increase in survival and complete tumor regression in more than 50 percent of mice."

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I just saw that article...sounds very promising w/ tumor regression in more than 50 percent of mice. Wow!! Sounds like excellent news. I am a long-term holder and am losing a bunch of money but just bought 4000 more shares to trade in the low 4's. I almost sold them for a 2000 profit today but decided to hang on since it closed at the HOD price.

    • The complete tumor regression is the key. This could be the news needed to make a Provenge cocktail the first in class for early stage cancers. It is a very important clinical study.

      Sentiment: Strong Buy

 
DNDN
2.690.00(0.00%)Apr 15 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Yahoo! Inc.
NasdaqGSTue, Apr 15, 2014 4:00 PM EDT
Zebra Technologies Corp.
NasdaqGSTue, Apr 15, 2014 4:00 PM EDT